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Abstract
Background: Delivery of a small for gestational age (SGA) infant has been associated with increased maternal risk of
ischemic heart disease (IHD). It is uncertain whether giving birth to SGA infant is a specific determinant of later IHD,
independent of other risk factors, or a marker of general poor health. The purpose of this study was to investigate the
association between delivery of a SGA infant and maternal risk for IHD in relation to traditional IHD risk factors.
Methods and Findings: Risk of maternal IHD was evaluated in a population based cross-sectional study of 6,608 women
with a prior live term birth who participated in the National Health and Nutrition Examination Survey (1999–2006), a
probability sample of the U.S. population. Sequence of events was determined from age at last live birth and at diagnosis of
IHD. Delivery of a SGA infant is strongly associated with greater maternal risk for IHD (age adjusted OR; 95% CI: 1.8; 1.2, 2.9;
p=0.012). The association was independent of the family history of IHD, stroke, hypertension and diabetes (family history-
adjusted OR; 95% CI: 1.9; 1.2, 3.0; p=0.011) as well as other risk factors for IHD (risk factor-adjusted OR; 95% CI: 1.7; 1.1, 2.7;
p=0.025). Delivery of a SGA infant was associated with earlier onset of IHD and preceded it by a median of 30 (interquartile
range: 20, 36) years.
Conclusions: Giving birth to a SGA infant is strongly and independently associated with IHD and a potential risk factor that
precedes IHD by decades. A pregnancy that produces a SGA infant may induce long-term cardiovascular changes that
increase risk for IHD.
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Introduction
Ischemic heart disease (IHD) is an important cause of mortality
and morbidity globally [1,2]. Although methods of effective risk
factor reduction are available, the prediction of IHD is limited [3].
Current risk estimation models misclassify a substantial proportion
of individuals and their use in low income countries is limited
[4,5]. Moreover, those models classify 95% of women less than 70
years old as low risk, despite that almost half of them will develop
IHD in their lifetime [6]. However, cardiovascular and metabolic
stress associated with pregnancy provides a unique opportunity to
estimate woman’s lifetime risk [7]. Thus greater knowledge of
IHD risk factors might improve the ability to predict vascular
disease events and information related to pregnancy and childbirth
may help aid prognostication for middle aged women [7].
Association between low birth weight of the offspring and
increased maternal mortality and morbidity including risk of IHD
has been reported [8–12]. However, it remains unknown if the
infants low birth weight is a specific determinant of later IHD,
independent of other risk factors, or a marker of general poor
health. Addressing those questions is essential to evaluate the
potential role of a delivery of a small infant in the risk of IHD.
The mechanism linking delivery of a low birth weight infant and
greater risk of IHD in the mother is also uncertain. It has been
postulated that the association between delivery of a small for
gestational age (SGA) infant and the risk of IHD is due to common
genetic and environmental factors, including intrauterine envi-
ronment [9–13]. The latter was proposed because of the
intergenerational correlation of low birth weight and putative
intrauterine programming across generations [14]. Genetic and
environmental factors tend to persist within families. Thus if SGA
and IHD have common causes they would confound the
relationship between SGA and IHD. Family history of IHD and
related disorders would be a marker of those common causes and
adjustment for family history would decrease or abolish the
association between SGA and IHD.
However, pregnancy resulting in delivery of a SGA infant is
associated with lower concentrations of Placental Growth Factor
in maternal circulation, a factor shown to stimulate long-term
angiogenesis in ischemic heart [15,16]. Thus, it is plausible that
SGA pregnancy is associated with deficiency of angiogenic
placenta derived growth factors in maternal circulation, decreased
angiogenesis and repair of the coronary circulation, resulting in
IHD in later life. We hypothesize that delivery of a SGA infant is
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33047an independent risk factor for maternal IHD. We postulate that
the association between delivery of a SGA infant and greater risk
of IHD is not related to shared by both conditions genetic or
environmental causes, and may result from long term cardiovas-
cular changes initiated during a pregnancy that ended with the
delivery of a SGA infant. A similar hypothesis has been proposed
and long term cardiovascular changes following pregnancy have
been observed in pregnancies complicated by preeclampsia [17–
21].
Methods
Ethics Statement
Institutional Review Board approval was obtained and the
participants gave written informed consent.
Study design and participants
The National Health and Nutrition Examination Survey
(NHANES) is a nationally representative complex-sample survey
of the U.S. population, designed to provide an estimate of the
health status in the general population [22]. Between 1999 and
2006 more than 40,000 individuals were surveyed using a
stratified, multistage cluster-probability design. To improve
reliability of the statistical estimates the survey oversampled non-
Hispanic Blacks, Mexican Americans, adolescents, older adults
and low-income persons. The participants underwent a household
interview, physical examination and biological sample collection in
mobile examination centers. The NHANES received NCHS
Research Ethics Review Board Approval. A total of 6,883 female
participants reported a live term birth, 275 (3.6%) of them had
missing data on occurrence of IHD. Analyses were conducted in
remaining 6,608 women who had delivered a term live born
infant.
Definitions
Delivery of a SGA infant was self-reported and defined as giving
birth to live born infant at or after 37 weeks of gestation with a
birth weight ,2,500 g. The self-reported gestational age at
delivery and birth weight were recorded in those prespecified
categories. Age at the time of participation, self reported age at the
last live birth, and at the diagnosis of first IHD event were
recorded. Family history of IHD, stroke or hypertension or
diabetes was reported by a participant if a diagnosis of those
disorders had been made in a relative of the participant. Collected
information included a history in grandparents, parents, brothers
or sisters of IHD, hypertension or stroke prior to age 50, or history
of diabetes at any age. Self-reported history of stroke, cancer and
breast cancer were also recorded in the NHANES survey.
Risk factors for IHD were documented or measured at the time
of NHANES examination. Hypertension and diabetes were
diagnosed by health professionals and reported by participants.
Race and ethnicity, marital status, education and income were self
reported. Reported annual household income was reported in
$5,000 increments. Inactivity was reported as number of hours
spent daily watching television or in front of a computer. Persons
who reported smoking at least 100 cigarettes in a lifetime were
categorized as smokers. Current smoking status was also assessed
with serum cotinine concentrations and was categorized as
detectable ($0.05 ng/mL) or non-detectable (,0.05 ng/mL).
The amounts of alcohol and dietary fiber intake were determined
during dietary interview recall of food consumed during the 24-
hour period prior to the interview. The daily intake was estimated
using the US Department of Agriculture (USDA) Food and
Nutrient Databases for Dietary Studies [23–25]. The USDA
1994–98 Survey Nutrient Database was used to code and report
the NHANES 1999–2000 data [22].
The serum concentrations of lipids and c-reactive protein were
measured using methodology described previously (http://www.
cdc.gov/nchs/nhanes/nhanes_questionnaires.htm). The measure-
ments of triglycerides and low density cholesterol were made in a
subsample of participants who fasted for 8 to 24 hours. The total
and low density cholesterol values were categorized based on
definition of dyslipidemia and high cholesterol proposed by the
Adult Treatment Panel III and of high density cholesterol
corresponding roughly to 10
th percentile observed in the
NHANES [26].
Main outcome
IHD included coronary heart disease, angina pectoris or
myocardial infarction diagnosed by a physician or health
professional and reported by participants. Those outcomes were
previously validated among NHANES participants [5,27,28].
Statistical analysis
All analyses accounted for probability sampling, stratification
and clustering in the survey design. For variables that were not
complete the missing values were estimated by multiple multivar-
iate imputation. The unweighted frequencies represent prevalence
of those variables in the analyzed sample. The frequencies
accounting for the sampling design of the survey represent the
estimated prevalence in the U.S. population. The population
estimates of IHD across categories of participants’ characteristics
also accounted for sampling design of the survey. To compare the
prevalence of IHD across participants’ characteristics we used
logistic regression adjusted for age and use of antihyperlipidemic
medications.
Multivariable logistic regression was used to evaluate the
associations between delivery of a SGA infant and the risk of
IHD, cancer, breast cancer and stroke and the relationships
between the risk of IHD and traditional risk factors for IHD,
including family history. The adjustment for traditional risk factors
of IHD was performed to demonstrate their effect on the
relationship between giving birth to a SGA infant and risk of
IHD. We evaluated three multivariable models of the association
between SGA and IHD which adjusted for: traditional IHD risk
factors, traditional risk factors and family history and risk factors
used in the Framingham risk score (age, hypertension, diabetes,
smoking, total and HDL cholesterol).
The association between delivery of a SGA infant and the risk of
IHD was also modeled using time to event analysis. Age was used
as the time scale, age at last live birth as time of study entry and
age at IHD diagnosis was taken as the event. Using age at last live
birth as the time of study entry allowed to account for the time
interval between last live birth and diagnosis of IHD. Cumulative
probability of IHD curves were constructed with the use of the
Kaplan–Meier method for subjects with and without SGA infants.
Hazard ratios for IHD were calculated using proportional hazard
regression. Proportional hazard assumption was evaluated using
global and specific tests [29].
Mortality follow-up data from the date of survey participation
through December 31, 2006 were obtained from the NHANES
Linked Mortality Files linking NHANES data with death
certificate data found in the National Death Index.
All p values were two-sided and were considered significant if
,0.05. Statistical analyses were performed with the Stata software
package, version 11.1 (Stata Corporation, College Station, TX,
USA).
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Among 6,608 women in this study 453 had IHD. Increased risk
of IHD was associated in univariate analyses with age .50 years,
Black race, BMI.30 kg/m
2, inactivity, history of smoking,
detectable cotinine concentrations, low fiber diet, low educational
level, lower income, presence of diabetes, elevated hemoglobin
A1c, hypertension, low HDL cholesterol concentrations, high
concentrations of CRP, and delivery of a SGA infant. There was a
trend towards higher risk of IHD with no alcohol use compared to
moderate use, single marital status and high concentrations of
triglycerides. The risk of IHD was not significantly associated with
total cholesterol or LDL cholesterol concentrations (Table S1).
Three hundred nine women had delivered a SGA infant, which
corresponds to the national prevalence of 4.1% (95% confidence
interval, 3.5 to 4.8) among women with a prior term live birth.
The relative odds for IHD was almost 2 fold higher (9.6% vs.
5.7%) in women who delivered a SGA infant (age adjusted OR;
95% CI: 1.8; 1.2, 2.9; p=0.012) compared to women who
delivered infants that were not SGA (Fig. 1). The cumulative
probability of IHD among women who gave birth to a SGA infant
was also significantly higher (Log-rank test p=0.01) than among
women who did not deliver a SGA infant (Fig. 2). The hazard ratio
was similarly higher among women who gave birth to SGA infant
than in women who did not (hazard ratio (HR), 1.6; 95%
confidence interval (CI), 1.1–2.4; P=0.019). The association was
essentially unchanged among younger women, 65 years of age or
younger. Delivery of a SGA infant was not associated with greater
risk of cancer, breast cancer or stroke (Fig. 3).
Positive family histories of IHD, diabetes, stroke or hypertension
were associated with increased risk of IHD in the NHANES
women. However, the association between delivery of SGA infant
and increased risk of IHD remained unaffected by adjustment for
those family histories (Table 1). In multivariable analysis including
all studied IHD risk factors and SGA, adjusted for use of
antihyperlipidemic medications, only delivery of SGA infant,
diabetes, hypertension, age, history of smoking and low fiber diet
were independently associated with increased risk of IHD (Fig. 4).
The risk of IHD associated with delivery of SGA infant was
minimally attenuated in this multivariable model (risk factors
adjusted OR; 95% CI: 1.7; 1.1, 2.7; p=0.025) and was
comparable with the strongest risk factors, hypertension and
diabetes. In a fully adjusted model, accounting for all studied IHD
risk factors, SGA and family history , the risk of IHD associated
with delivery of a SGA infant did not change appreciably either
(risk factors adjusted OR; 95% CI: 1.7; 1.1, 2.8; p=0.022). Thus,
in a multivariable model after adjustment for all studied risk
factors, SGA remains independent risk factor and its effect remains
essentially unchanged. In a model that included SGA and risk
factors from the Framingham risk score of general cardiovascular
disease the variables SGA, hypertension, diabetes, age and
smoking were significantly associated with increased risk of IHD,
and concentrations of total cholesterol .240 mg/dl and HDL
cholesterol ,35 mg/dl were not. Models with and without SGA
or with and without antihyperlipidemic medications were
essentially unchanged. In a fully adjusted model using continuous
measurements of the covariates (age, BMI, total cholesterol, HDL,
LDL, triglycerides, CRP, fiber intake) the risk of IHD associated
with delivery of a SGA infant was essentially unchanged (risk
factors adjusted OR; 95% CI: 1.7; 1.1, 2.9; p=0.027).
There was no evidence of association of SGA with traditional
IHD risk factors except for smoking. The age adjusted odds of
hypertension (1.3; 0.9, 1.9; p=0.2), diabetes (0.8; 0.5–1.4; p=0.4),
elevated total and LDL cholesterol concentrations (1.1; 0.8, 1.7;
p=0.5 and 1.02; 0.6, 1.8; p=0.9, respectively) were not
significantly associated with giving birth to SGA infant. SGA
was associated with significantly higher age adjusted odds of
smoking (1.4; 1.04, 1.9; p=0.028).
In a stratified analysis SGA was associated with significantly
increased risk of IHD in smokers and in non-smokers. The risks of
IHD among smokers with and without SGA were higher than
among non-smokers. Among non-smokers the prevalence of IHD
was 9.7 (5.7–16.0)% for women with SGA infant and 5.3 (4.6–
6.1)% for women without SGA infant (P=0.02). Among smokers
the prevalence of IHD was 15.0 (9.5–22.9)% in women with SGA
infant and 6.3 (5.1–7.6)% in women without SGA infant
(P=0.0006).
The age adjusted prevalence of IHD in women with and
without SGA infant was respectively 2.4% and 1.2% among
women less than 50 and 17.4% and 10.8% among women 50
years or older. The median time interval from last delivery to
occurrence of IHD was 30 (interquartile range: 20, 36) years. The
time interval from last delivery to occurrence of IHD was not
significantly different between women with and without SGA
infant (median; interquartile range: 29; 20–35 and 30; 20–39;
respectively p=0.3). Among 54 women who later died due to IHD
the mean age at death was 86 for women with SGA infant, 80 for
women with non-SGA infant and 79 years for all women in the
NHANES population.
Discussion
Interpretation of the key findings
The primary finding of this study is that delivery of a SGA
infant is strongly associated with increased maternal risk of IHD.
In the multivariable analysis the association was independent of
the family history of IHD, diabetes, stroke or hypertension as well
as other risk factors for IHD. Delivery of a SGA infant preceded
the presentation of IHD by a median of 30 years.
The strength of this study is its representativeness, generaliz-
ability of the findings and accounting for IHD risk factors. The
sampling scheme of the NHANES has been designed to represent
the entire U.S. population. Studies that previously reported an
Figure 1. Prevalence of ischemic heart disease in relation to
delivery of a small for gestational age infant. SGA, delivery of a
small for gestational age infant, a term live born infant with birth
weight ,2500 g. No SGA, prior delivery of a term live born infant that
was not small for gestational age. Population weighted proportion and
95% confidence intervals of the ischemic heart disease in women with
prior live birth, adjusted for age. p-value was calculated using weighted
logistic regression accounting for the sampling scheme of the survey
and adjusted for age.
doi:10.1371/journal.pone.0033047.g001
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not fully account for IHD risk factors [8–13]. Additionally, those
studies evaluated IHD mortality as outcome, which is subject to
confounding by factors that affect survival, such as socioeconomic
status [8,10–12], [30]. This could explain the non-specific
association between delivery of a SGA infant and greater risk for
all-cause mortality observed in those studies [8–12]. In this study
SGA was significantly associated exclusively with IHD, strength-
ening the causal inference. However, non-significant association
with stroke is likely due to smaller number of events, strokes, which
occurred in the study population of relatively young women. Our
analyses evaluated family history of IHD, hypertension or stroke
and diabetes. Those positive family histories were strongly
associated with increased risk of IHD. However, adjustment for
the positive family history did not affect the relationship between
delivery of a SGA infant and greater risk for IHD, suggesting that
family history is not a significant confounder. Two studies reported
an association between family history of premature death from
IHD and delivery of a low birth weight infant and an association
between increased risk of IHD in grandparents and delivery of a
SGA infant, suggesting that family history could confound the
relationship between delivery of a SGA infant and IHD [13], [31]
However, these studies reported only a modest increase of 9% for
a positive IHD history in parents and 16% increase for positive
IHD history in grandparents for women who had delivered a SGA
infant, indicating that the association between family history of
IHD and delivery of SGA infant is relatively weak and thus
unlikely to substantially confound the findings of this study
[13,31].
Traditional risk factors of IHD were evaluated in NHANES and
delivery of a SGA infant was one of six risk factors independently
associated with the risk of IHD in the multivariable analysis, an
effect that rivaled hypertension and diabetes. The effect of delivery
of a SGA infant on the risk of IHD was also independent of
hemoglobin A1c level and undiagnosed diabetes [32], both
potential confounders of the studied association [33,34]. Although
diabetes and elevated concentrations of hemoglobin A1c are
certainly correlated they also represent different phenomena e.g.
patient with elevated hemoglobin A1c might not be diagnosed
with diabetes and may have either undiagnosed diabetes or
glucose intolerance that do not meet the diagnostic criteria for
diabetes. We found no evidence of confounding by smoking status.
Although smoking is associated with giving birth to a SGA infant
and with increased risk of IHD, a significant association between
birth of SGA infant and increased risk of IHD was observed
among smokers as well as non-smokers. Also adjustment for
history of smoking as well as current cotinine concentrations in
multivariable analysis did not substantially affect the association
between birth of SGA infant and increased risk of IHD. The
strength and independence of other risk factors, together with the
ease of obtaining this information, suggest that delivery of a SGA
infant could be an important determinant of later risk for IHD in
women.
As a potential risk factor, delivery of SGA infant may help to
predict IHD and provide newer information on the origins of
atherosclerosis by identifying women at risk in their child-bearing
years, preceding the occurrence of IHD by a long time [35].
Earlier identification of women at high risk for IHD would provide
a longer time for risk factor reduction, which has been shown to be
effective in prevention of IHD [3]. However, the findings of this
study would need to be confirmed using prospective study design
to allow clinical use.
It has been proposed that the association between delivery of a
SGA infant and risk of IHD is due to shared genetic or
environmental factors, including intrauterine environment
[9,10,12,13,31]. The latter proposes that fetal programming,
Barker’s hypothesis, operates across generations [14]. However,
two observations in this study are incongruent with the common
cause hypothesis. First, genetic and environmental factors tend to
persist within the family, which is known as familial aggregation
[36]. A family history of IHD would be expected to be associated
with both delivery of SGA infant and greater IHD risk if both
Figure 2. Kaplan–Meier curves of the cumulative probability of
ischemic heart disease according to delivery of small for
gestational age infant. SGA, delivery of a small for gestational age
infant, a term live born infant with birth weight ,2500 g. No SGA, prior
delivery of a term live born infant that was not small for gestational age.
Number at risk, number of participants at risk of ischemic heart disease
(IHD) at age 20, 40, 60 and 80 years. Age was used as the time scale, age
at last live birth as time of study entry and age at IHD diagnosis was
taken as the event.
doi:10.1371/journal.pone.0033047.g002
Figure 3. Relative odds for breast cancer, cancer, stroke and
ischemic heart disease in mothers according to history of a
delivery of a small for gestational age infant. Breast cancer,
cancer, stroke and ischemic heart disease (IHD) were reported as
diagnosed by a physician. Population weighted odds ratios and 95%
confidence intervals of adverse outcomes in women with prior live term
birth of a small for gestational age infant comparing to women with
prior live term birth of an infant not small for gestational. The odds
ratios and 95% confidence intervals were obtained using weighted
logistic regression accounting for the sampling scheme of the survey
and adjusted for age. SGA, delivery of a small for gestational age infant,
a term live born infant with birth weight ,2500 g. No SGA, prior
delivery of a term live born infant that was not small for gestational age.
doi:10.1371/journal.pone.0033047.g003
Ischemic Heart Disease and Child’s Birth Weight
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history of IHD would be expected to attenuate the association
between delivery of SGA infant and risk of IHD. We found no
evidence of such attenuation. Second, shared genetic or environ-
mental causes of SGA and IHD would imply that risk factors of
IHD, including family history of IHD, would increase risk of IHD
as well as delivery of a SGA infant. Adjustment for those risk
factors would then attenuate or abolish the association between
delivery of a SGA infant and the risk of IHD. However, such
adjustment did not materially affect our findings, which would
support the hypothesis that pregnancy culminating in delivery of a
SGA infant may have a deleterious effect on maternal cardiovas-
cular system and is associated with long term cardiovascular
changes that culminate in greater IHD risk later in life. This
reasoning is further supported by observations that preeclampsia, a
placental disorder during pregnancy associated with increased risk
of delivery of a SGA infant, results in impaired endothelial
function and vasodilatation after the pregnancy and increased risk
of developing hypertension and IHD in later life [17–21]. The
alternative hypothesis that the SGA pregnancy could potentially
be an early manifestation of cardiovascular disease is unlikely
because of the observed lack of its association with the
hypertension or diabetes, expressions of cardiovascular disease.
Limitations of the analyses
The main limitation of this study is the cross-sectional design,
which generally is not well suited for causative inferences because
of lack of information on sequence of events and possibility of
incidence-prevalence bias. However, in this study the sequence of
events can be established because of known age at giving birth and
age at diagnosis of IHD. Moreover, IHD is very rare in
premenopausal women and thus unlikely to bias the findings
due to reverse causation [37]. The incidence-prevalence bias is
present if risk factor that results in death is underrepresented
among those with the disease. In this study if such bias would be
present women with SGA infants would be underrepresented
among those with IHD, resulting in weakening of the observed
association or falsely negative findings.
The retrospective assessment of birth weight could also
potentially be subject to bias. However, maternal recall of infants
birth weights was shown to be relatively accurate [38,39]. The
recalled birth weight was reported to be within 250 g in almost
80% of recorded birth weights and on average differ by 86 g at
mean of 18 and 57 years after giving birth, respectively [38,39].
The recalled infants’ birth weights were concluded to be valuable
for studies linking pregnancy history with the risk of chronic
disease in later life [39]. Bias in retrospective assessment of birth
weight and directionality of the association between SGA and
IHD is also unlikely because of the specificity of the association. In
this study giving birth to a SGA infant was associated exclusively
Table 1. Risk of ischemic heart disease in relation to delivery of a small for gestational age infant and family history.
Risk of IHD
Sample N (%)*
Population proportion
(% (95% CI){
Age adjusted
OR (95% CI){ p
Age + FH adjusted
OR (95% CI){ p
SGA 309 (4.7) 4.1 (3.5, 4.8) 1.8 (1.2, 2.9) 0.012 1.9 (1.2, 3.0) 0.011
FH of IHD 971 (14.7) 17.6 (16.2, 19.1) 2.5 (1.8, 3.4) ,0.0001 1.9 (1.3, 2.8) 0.001
FH of stroke or
hypertension
1,602 (24.2) 35.1 (33.2, 37.1) 2.2 (1.7, 2.9) ,0.0001 1.8 (1.3, 2.4) ,0.0001
FH of diabetes 3,353 (50.7) 51.2 (49.1, 53.4) 1.7 (1.3, 2.1) ,0.0001 1.5 (1.2, 1.9) 0.003
SGA, prior delivery of a small for gestational age infant. FH, history of a first degree relative with: ischemic heart disease (IHD), stroke or hypertension, or with diabetes.
*Unweighted number and proportion of observations for each characteristic in the sample;
{Population-weighted estimates of the proportion and 95% confidence interval of the U.S. population of women with prior live birth;
{OR (95%CI), odds ratios, 95% confidence intervals and p-values were calculated using weighted logistic regression accounting for the sampling scheme of the survey
and adjusted for age or age and family history of ischemic heart disease, stroke or hypertension or of diabetes, thus representing the risks in the U.S. population.
doi:10.1371/journal.pone.0033047.t001
Figure 4. Risk of ischemic heart disease in relation to the
traditional risk factors and delivery of a small for gestational
age infant in a multivariable analysis. Multivariable logistic
regression model of preterm birth included all investigated traditional
risk factors for ischemic heart disease and SGA. IHD, ischemic heart
disease. SGA, delivery of a small for gestational age infant, a term live
born infant with birth weight ,2500 g. No SGA, prior delivery of a term
live born infant that was not small for gestational age. Smoking,
smoked at least 100 cigarettes in lifetime. Low fiber diet, less than 25 g
of fiber consumed daily. Antihyperlipidemic med., use of antihyperlip-
idemic medication at the time of examination. BMI, body mass
index$30. Inactivity, number of hours spent daily watching television
or in front of the computer. Income, annual household income reported
in $5,000 increments. Detectable cotinine, serum cotinine concentra-
tions $0.05 ng/mL. Alcohol, no alcohol use comparing to a moderate
,15 g/day alcohol consumption. Total cholesterol, total serum
cholesterol $240 mg/dl. LDL cholesterol, LDL serum cholesterol
$160 ng/ml. HDL cholesterol, HDL serum cholesterol ,35 mg/dl.
Triglycerides, serum triglycerides $200 mg/dl. Serum CRP, serum C-
reactive protein $1 mg/dl. Hgb A1c, concentration of Hemoglobin A 1c
.5.6%. OR (95% CI), population weighted odds ratios and 95%
confidence intervals of ischemic heart disease in women with prior live
term birth. The odds ratios and 95% confidence intervals were obtained
using weighted logistic regression accounting for the sampling scheme
of the survey and adjusted for all risk factors of ischemic heart disease.
doi:10.1371/journal.pone.0033047.g004
Ischemic Heart Disease and Child’s Birth Weight
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expected if the findings would be biased.
The misclassification of exposures due to inaccuracy of self-
reported preterm or term birth is also unlikely. The self-reported
estimates of gestational age, decades after giving birth, were found
to be sufficiently accurate for both research and clinical us.
Specifically, 86% of those estimates were reported to be within 1
week and 94% within 2 weeks of gestational age recorded in
medical records [40].
The pregnancy information available did not contain data on
congenital malformations. However, major congenital malforma-
tions at term are uncommon and occur with a prevalence of 2–3%
[41]. Thus, congenital malformations are very unlikely to result in
a significantly bias and even less likely in differential misclassifi-
cation.
Information on multifetal pregnancies was not available in the
study. However, among the women participating in the study only
1–2% of pregnancies were multifetal [42]. Additionally, only 40%
of such pregnancies deliver at term [42]. Thus, the effect of
multifetal pregnancies on the findings is likely to be small.
Related to survival is possibility that higher risk of IHD in
women with SGA infants is related to longer duration rather than
incidence of the IHD compared to other women. This potential
bias is also unlikely because women with SGA infants had mean
age at diagnosis of IHD similar to women who did not deliver
SGA infant (58 and 57 years, respectively). The age at death due
to IHD was also similar between women who had SGA infant and
in all women who died due to IHD in the NHANES population
(85 and 82 years, respectively).
Some of the risk factors for IHD could have been subject to the
behavioral modifications and pharmacological interventions after
diagnosis of IHD. However, in this study all of the investigated risk
factors were associated with the greater risk of IHD, with the
exception of total cholesterol and low density lipoprotein
concentrations (Table 1). Our analyses were adjusted for the use
of antihyperlipidemic medications, alcohol consumption, fiber
intake and amount of exercise. Information on other dietary and
behavioral modifications was not available.
The associations between total cholesterol and low density
lipoprotein concentrations and IHD were not statistically signif-
icant. This could reflect lower strengths of these associations
observed in women [43,44] and smaller number of participants
who had those concentrations measured in this study. Alterna-
tively, lack of a significant association could be a specific
characteristic of parous women investigated in this study, because
both associations were significant among all the women in
NHANES study [5,28].
In this study the delivery of a SGA infant, physician’s
diagnosis of IHD and family history were self reported.
However, bias is unlikely because the prevalence of SGA infants
in this study closely approximates the national statistics and the
self reported diagnosis of IHD in the NHANES study has been
previously validated [27,45], [5]. Gestational age and birth
weight were reported and analyzed using pre-specified categories
rather than cut-offs selected during the analysis. The self
reported family history of IHD has limited accuracy and
sensitivity and specificity of approximately 75% and 90%,
respectively [46]. However, the family history adds significant
predictive information over traditional risk factors and in this
study showed a degree of association with IHD observed in
prospective studies [47].
The association with breast cancer was not significant and
consistent with no effect. However, this could also be due to a
small number of breast cancer events and a common causative
mechanism for breast cancer and IHD acting in opposite
directions. Prior studies have proposed that angiogenesis may
underlie greater atherosclerosis and tumor development and
could provide an alternative explanation [15]. The composite
outcome of IHD, consisting of diagnosis of coronary heart
disease, myocardial infarction or angina, was chosen because of a
relatively small number of each individual outcome among
exposed women, which would limit our ability to adjust for IHD
risk factors. SGA was associated with each individual outcome
coronary heart disease, myocardial infarction, angina with similar
strength as with a composite outcome (age adjusted OR; 95% CI:
1.9; 1.1, 3.2; p=0.023: 2.0; 1.002, 3.9; p=0.049 and 1.7; 0.97,
3.0; p=0.06).
Data on other complications of pregnancy were not available
in NHANES. However, many of the common pregnancy
complications are associated with fetal growth abnormalities,
especially preeclampsia, pre-pregnancy chronic hypertension,
and smoking in pregnancy. Furthermore, unlike other complica-
tions of pregnancy, the SGA phenotype is well defined and has
better reliability and validity. Pregnancy complications also often
cluster and affect the occurrence of SGA. For example, chronic
hypertension increases risk of preeclampsia, and smoking
decreases the risk [48,49]. Large studies of precisely defined
complications of pregnancy would be needed to determine the
effect complications of pregnancy have on the risk of IHD
independently of SGA.
Implications and generalizability
In summary, delivery of a SGA infant is strongly and
independently associated with later IHD in women, and
potentially a risk factor that precedes the onset of IHD by
decades. These results suggest that a pregnancy that produces a
SGA infant induces long term cardiovascular changes that
augment risk for clinical IHD. In this study we show that SGA
is associated with the risk of IHD independently of traditional risk
factors, but not necessarily independently of potential mediating
factors and other pregnancy complications. However, birth
weight is relatively easily and reliably obtainable for potential
prediction of IHD in comparison to other complications of
pregnancy.
Future prospective studies of IHD prediction in women
accounting for their pregnancy outcomes could determine the
predictive and discriminatory power of delivery of SGA infant as a
risk factor in prediction of IHD.
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